Remove 2028 Remove Automation Remove Pharmaceutical
article thumbnail

Environmental Compliance and Pharmaceutical Quality Standards Pave the Way for Transformational Growth in Chromatography

Frost & Sullivan Manufacturing

By enabling precise separation and analysis of complex mixtures, chromatography plays a crucial role in ensuring pharmaceutical purity, food safety, and environmental compliance. billion in 2028. With robust support and training, these technologies are also enhancing lab efficiency and return on investment (ROI).

article thumbnail

ABB Expands Support for Irish Automation Market with New Robotics Business Office

i4.0 today

ABB’s Robotics and Discrete Automation business is expanding its presence in Ireland with the opening of a new office in Dundalk, Co Louth. According to a 2021 reported by Fortune Business Insights , the Irish market for industrial automation is set to grow at a rate of 10 percent between 2021 and 2028, from USD 1.33

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Robotic surgery to benefit from advanced processors and AI, says AMD

Robotics Business Review

and that number could reach 1 million in 2028, according to the National Library of Medicine (NLM). They’re used in industrial automation, automotive, gaming, servers and data centers, and increasingly in healthcare.” In 2021, almost 644,000 robotic surgeries were performed in the U.S.,

Robotics 127
article thumbnail

Back In Action: An MCMT Special

Dinesh Mishra

Ltd: The CHIRON Group is the proprietor of the CHIRON, STAMA, and FACTORY5 brands for new machines, as well as the automation brand GREIDENWEIS, CMS for refurbishment, and HSTEC for motor spindles and fixtures. At present we see good demand in the fields of automation, 5-axis machines and Industry 4.0 technologies.

article thumbnail

Healthcare & Life Sciences 2025: The Future of Technology, Transformation, and Growth

Frost & Sullivan Manufacturing

By 2025, the industry is projected to surpass $3 trillion , fueled by innovations in pharmaceuticals, diagnostics, medical devices, and AI-powered healthcare solutions. AI-powered chatbots, automated revenue cycle management, and generative AI tools are helping providers cut operational costs while improving efficiency.

article thumbnail

10 Game-Changing Transformations Reshaping the Global Molecular Biomarkers Industry by 2030

Frost & Sullivan Manufacturing

Click here to download Top Transformations Impacting Growth in Global Molecular Biomarkers Market, Forecast to 2030 Rank Strategic Imperative Category Strategic Imperative Impact Score (%) Timeline Duration Growth Curve 1 Industry Convergence Cross-sector partnerships between pharmaceuticals and AI companies to enhance biomarker precision 72 2025-2039 (..)